[1]CurrentPatentAssignee:DANA-FARBERCANCERINSTITUTE-WO2019/25562,2019,A1Locationinpatent:Page/Pagecolumn227;237
129825-11-2
2003-10-3
79779-64-9
205178-80-9
63958-66-7 | 4,5-dihydroxyphthalic acid | AA00EU0M | MFCD18976691
60003-46-5 | 4-(Hexyloxy)phenylacetic acid | AA00EWXL | MFCD01649167
597-64-8 | TETRAETHYLTIN | AA00EZHJ | MFCD00009020
58390-42-4 | 4-Aminopyrazolo[5,1-c][1,2,4]triazine-3-carbonitrile | AA00F1NB | MFCD03829962
6113-65-1 | N-(4-Methoxybenzyl)-2-nitroaniline | AA00F36O | MFCD02039489
61689-40-5 | 1,3,4-OXATHIAZOLE-5-CARBOXYLIC ACID, 2-OXO-, ETHYL ESTER | AA00F4TA | MFCD13192139
65541-95-9 | 5,7-Dimethyl-1,2,3,4-tetrahydro-1,8-naphthyridine | AA00F7MF | MFCD13705330
6933-10-4 | 4-Bromo-3-methylaniline | AA00F9TR | MFCD00007828
6684-06-6 | 2-Chloropyridine-3-sulfonyl chloride | AA00FA3S | MFCD05664916
717907-75-0 | N-[3-[[[2-[(2,3-Dihydro-2-oxo-1h-indol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]-2-pyridinyl]-n-methyl-methanesulfonamide | AA00FADA | MFCD16038299